IL163305A - Azacycloalkyl glucosaminide phosphate as immunoeffector compounds and pharmaceutical compositions for propylactic and therapeutic treatment of infectious and therapeutic treatment of infectious and other diseases comprising the same - Google Patents
Azacycloalkyl glucosaminide phosphate as immunoeffector compounds and pharmaceutical compositions for propylactic and therapeutic treatment of infectious and therapeutic treatment of infectious and other diseases comprising the sameInfo
- Publication number
- IL163305A IL163305A IL16330502A IL16330502A IL163305A IL 163305 A IL163305 A IL 163305A IL 16330502 A IL16330502 A IL 16330502A IL 16330502 A IL16330502 A IL 16330502A IL 163305 A IL163305 A IL 163305A
- Authority
- IL
- Israel
- Prior art keywords
- infectious
- therapeutic treatment
- propylactic
- azacycloalkyl
- diseases
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/543—Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
- A61K47/544—Phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/549—Sugars, nucleosides, nucleotides or nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Virology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biomedical Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2002/003581 WO2003066065A1 (fr) | 2002-02-04 | 2002-02-04 | Traitement prophylactique et therapeutique de maladies infectieuses et autres maladies utilisant des composes immuno-effecteurs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL163305A true IL163305A (en) | 2010-10-31 |
Family
ID=27732076
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL16330502A IL163305A (en) | 2002-02-04 | 2002-02-04 | Azacycloalkyl glucosaminide phosphate as immunoeffector compounds and pharmaceutical compositions for propylactic and therapeutic treatment of infectious and therapeutic treatment of infectious and other diseases comprising the same |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP1482955B1 (fr) |
| JP (1) | JP2005523902A (fr) |
| KR (1) | KR100858947B1 (fr) |
| CN (2) | CN1622812A (fr) |
| AU (1) | AU2002255513B2 (fr) |
| BR (1) | BR0215583A (fr) |
| CA (1) | CA2474402C (fr) |
| CZ (1) | CZ2004861A3 (fr) |
| ES (1) | ES2453903T3 (fr) |
| HU (1) | HUP0402570A3 (fr) |
| IL (1) | IL163305A (fr) |
| MX (1) | MXPA04007491A (fr) |
| NO (1) | NO20043693L (fr) |
| NZ (1) | NZ534592A (fr) |
| WO (1) | WO2003066065A1 (fr) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60234386D1 (de) * | 2002-02-04 | 2009-12-24 | Corixa Corp | Neue immuneffektor-verbindungen |
| US6911434B2 (en) | 2002-02-04 | 2005-06-28 | Corixa Corporation | Prophylactic and therapeutic treatment of infectious and other diseases with immunoeffector compounds |
| WO2006093352A1 (fr) * | 2005-03-04 | 2006-09-08 | Riken | Compose a structure cyclique et son utilisation |
| CN105131051B (zh) | 2009-06-05 | 2020-07-10 | 传染性疾病研究院 | 合成的吡喃葡萄糖脂佐剂 |
| GB201101331D0 (en) | 2011-01-26 | 2011-03-09 | Glaxosmithkline Biolog Sa | Compositions and uses |
| GB201113570D0 (en) | 2011-08-05 | 2011-09-21 | Glaxosmithkline Biolog Sa | Vaccine |
| US20220273789A1 (en) | 2019-07-21 | 2022-09-01 | Glaxosmithkline Biologicals Sa | Therapeutic viral vaccine |
| US20230234992A1 (en) | 2020-06-05 | 2023-07-27 | Glaxosmithkline Biologicals Sa | Modified betacoronavirus spike proteins |
| EP4032547A1 (fr) | 2021-01-20 | 2022-07-27 | GlaxoSmithKline Biologicals S.A. | Fragments dérivés du hsv 1 fce pour le traitement du hsv |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6113918A (en) * | 1997-05-08 | 2000-09-05 | Ribi Immunochem Research, Inc. | Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors |
| JP5004261B2 (ja) * | 2000-05-19 | 2012-08-22 | コリクサ コーポレイション | 単糖類及び二糖類に基づく化合物を用いた感染症及び他の疾患の予防的並びに治療的な処置 |
| EP1311522B1 (fr) | 2000-08-04 | 2006-03-22 | Corixa Corporation | Nouveaux composes immuno-effecteurs |
| DE60234386D1 (de) * | 2002-02-04 | 2009-12-24 | Corixa Corp | Neue immuneffektor-verbindungen |
-
2002
- 2002-02-04 WO PCT/US2002/003581 patent/WO2003066065A1/fr active Application Filing
- 2002-02-04 CZ CZ2004861A patent/CZ2004861A3/cs unknown
- 2002-02-04 CN CNA028284356A patent/CN1622812A/zh active Pending
- 2002-02-04 ES ES02724914.3T patent/ES2453903T3/es not_active Expired - Lifetime
- 2002-02-04 IL IL16330502A patent/IL163305A/xx unknown
- 2002-02-04 BR BR0215583-4A patent/BR0215583A/pt not_active Application Discontinuation
- 2002-02-04 CA CA2474402A patent/CA2474402C/fr not_active Expired - Lifetime
- 2002-02-04 KR KR1020047011969A patent/KR100858947B1/ko active IP Right Grant
- 2002-02-04 HU HU0402570A patent/HUP0402570A3/hu unknown
- 2002-02-04 EP EP02724914.3A patent/EP1482955B1/fr not_active Expired - Lifetime
- 2002-02-04 AU AU2002255513A patent/AU2002255513B2/en not_active Expired
- 2002-02-04 JP JP2003565489A patent/JP2005523902A/ja not_active Withdrawn
- 2002-02-04 NZ NZ534592A patent/NZ534592A/en not_active IP Right Cessation
- 2002-02-04 CN CN200710161297XA patent/CN101138566B/zh not_active Expired - Lifetime
- 2002-02-04 MX MXPA04007491A patent/MXPA04007491A/es active IP Right Grant
-
2004
- 2004-09-03 NO NO20043693A patent/NO20043693L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ES2453903T3 (es) | 2014-04-08 |
| KR100858947B1 (ko) | 2008-09-17 |
| EP1482955A1 (fr) | 2004-12-08 |
| WO2003066065A1 (fr) | 2003-08-14 |
| CA2474402A1 (fr) | 2003-08-14 |
| CA2474402C (fr) | 2012-09-11 |
| EP1482955B1 (fr) | 2013-12-25 |
| HUP0402570A2 (hu) | 2005-10-28 |
| CN101138566A (zh) | 2008-03-12 |
| BR0215583A (pt) | 2004-12-21 |
| KR20040081174A (ko) | 2004-09-20 |
| HUP0402570A3 (en) | 2006-02-28 |
| CN101138566B (zh) | 2012-05-23 |
| NZ534592A (en) | 2006-06-30 |
| EP1482955A4 (fr) | 2008-08-06 |
| JP2005523902A (ja) | 2005-08-11 |
| MXPA04007491A (es) | 2004-11-10 |
| NO20043693L (no) | 2004-09-03 |
| AU2002255513A1 (en) | 2003-09-02 |
| CZ2004861A3 (cs) | 2004-12-15 |
| AU2002255513B2 (en) | 2008-03-06 |
| CN1622812A (zh) | 2005-06-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0200493A2 (en) | Pharmaceutical compositions comprising sulphonyl-amino-carbonyl derivatives for the treatment of nuclear factor-kappa b mediated diseases | |
| IL230815A0 (en) | Dictopiperazine compounds and pharmaceutical preparations containing them for the treatment of T-cell mediated diseases | |
| HUP0401514A3 (en) | Pharmaceutical compositions for the treatment of asthma | |
| AU2002329990A1 (en) | Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith | |
| NO324227B1 (no) | Cyclopropyl-kondenserte pyrrolidin-baserte forbindelser, farmasoytiske blandinger og kombinasjoner inneholdende slike samt anvendelse av slike for fremstilling av medikamenter for behandling av sykdommer | |
| HUP0301815A3 (en) | Mono and disaccharide-based pharmaceutical composition for infections and other diseases and prophylactic and therapeutic treatment | |
| HUP0203437A3 (en) | Use of resorcinol derivatives for producing pharmaceutical compositions for treatment of immune diseases | |
| IL169338A0 (en) | Therapeutic formulations for the treatment of beta-amyloid related diseases | |
| IL157656A (en) | Metalloproteinase inhibitors, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments for the treatment of diseases mediated by metalloproteinase enzymes | |
| HUP0302726A3 (en) | Methods of administering pharmaceutical composition containing epothilone analogs for the treatment of cancer and of preparation the same | |
| ZA200707934B (en) | Thereapeutic formulations for the treatment of beta-amyloid related diseases | |
| IL161070A0 (en) | Compositions for the treatment of infectious diseases | |
| EP1648474A4 (fr) | Methodes et compositions pharmaceutiques pour cicatriser des lesions | |
| HK1100812A1 (en) | Composition for the prophylaxis/treatment of hbv infections and hbv- mediated diseases | |
| IL173148A0 (en) | Methods and pharmaceutical compositions for healing wounds | |
| DE60218375D1 (de) | Pharmazeutische Zusammensetzung zur Behandlung gynäkologischer Erkrankungen | |
| IL163305A (en) | Azacycloalkyl glucosaminide phosphate as immunoeffector compounds and pharmaceutical compositions for propylactic and therapeutic treatment of infectious and therapeutic treatment of infectious and other diseases comprising the same | |
| HUP0401392A3 (en) | Use of composition comprising anti-hla-antibody for treatment of diseases involving prolierative immune response | |
| EP1416795A4 (fr) | Compositions et procedes pour le traitement de maladies mitochondriales | |
| TWI347845B (en) | Pharmaceutical compositions,combinations,and kits for the treatment of respiratory diseases and use of the same | |
| AU2002325169A1 (en) | Pharmaceutical composition for the prophylaxis and/or treatment of virus diseases | |
| RS60604A (en) | Carboxamidine derivatives and their use in the treatment of vascular diseases | |
| EP1472273A4 (fr) | Compositions et methodes de traitement de maladies d'origine immune | |
| HUP0400925A3 (en) | Azolycarbynol derivatives of aryl (or heteroaryl) for producing pharmaceutical compositions for the treatment of respiratory diseases | |
| EP1551456A4 (fr) | Composition pharmaceutique servant a prevenir et a traiter des maladies renales |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| KB | Patent renewed |